Sharp Phillip A's Form 4 filing
Alnylam Pharmaceuticals, Inc.ALNY · filed Aug 17, 2022
- Accession no.
- 0001735276-22-000069
- Filed
- Aug 17, 2022
- Trade date
- Aug 15, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $7.76M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sharp Phillip ACIK 0001226295 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Common Stock | MOption exerciseAcquired | +30,000 | $30.09 | +$902,700 | 30,000 | Direct | |
| Aug 15, 2022 | Common Stock | MOption exerciseAcquired | +3,670 | $63.86 | +$234,366.2 | 33,670 | Direct | |
| Aug 15, 2022 | Common Stock | SSaleDisposed | −98 | $226.16 | −$22,163.68 | 33,572 | Direct | |
| Aug 15, 2022 | Common Stock | SSaleDisposed | −1,218 | $228.33F2 | −$278,105.94 | 32,354 | Direct | |
| Aug 15, 2022 | Common Stock | SSaleDisposed | −11,600 | $229.93F3 | −$2,667,188 | 20,754 | Direct | |
| Aug 15, 2022 | Common Stock | SSaleDisposed | −16,186 | $230.71F4 | −$3,734,272.06 | 4,568 | Direct | |
| Aug 15, 2022 | Common Stock | SSaleDisposed | −3,853 | $231.65F5 | −$892,547.45 | 715 | Direct | |
| Aug 15, 2022 | Common Stock | SSaleDisposed | −715 | $232.81F6 | −$166,459.15 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Common Stock | MOption exerciseDisposed | −3,670 | $0.00 | $0 | 0 | Direct | |
| Aug 15, 2022 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Sale prices ranged from $228.00 to $228.80.
Referenced by the price of 1 transaction in Table I.
- F3
Sale prices ranged from $229.29 to $230.29.
Referenced by the price of 1 transaction in Table I.
- F4
Sale prices ranged from $230.30 to $231.30.
Referenced by the price of 1 transaction in Table I.
- F5
Sale prices ranged from $231.31 to $232.26.
Referenced by the price of 1 transaction in Table I.
- F6
Sale prices ranged from $232.53 to $233.16.
Referenced by the price of 1 transaction in Table I.